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Wednesday, March 4, 2009 593acrowding, which in turn inhibits receptor activation. [1] T. Huber, S. Menon,
and T.P. Sakmar. 2008. Current Topics. Structural Basis for Ligand Binding
and Specificity in Adrenergic Receptors: Implications for GPCR-targeted
Drug Discovery. Biochemistry 47, in press.
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Activation of human pancreatic phospholipase A2 (PLA2) in the presence of
DPPC/DPPG (7:3) vesicles was induced by a temperature shift from 4 to 38
oC. PLA2 activity was monitored by changes in fluorescence of bis-Pyrene-
PC (2.5 mol % in the membranes), while simultaneous far- and near-UV cir-
cular dichroism (CD) spectra identified changes in the secondary and tertiary
structures of the protein in real time. The 4-to-38 oC temperature shift caused
dramatic changes in both bis-Pyrene-PC fluorescence and the protein CD
spectra. The monomer fluorescence signal of bis-Pyrene-PC rapidly increased
and the excimer signal decreased, demonstrating PLA2 activation. Drastic
weakening in the a-helical CD signal of the protein, i.e., a 20% decrease
in the n-p* transition intensity at 222 nm, was detected upon enzyme activa-
tion. The a-helical signal exhibited a significantly smaller change upon a sim-
ilar temperature shift under non-catalytic conditions (1 mM EGTA), while
little changes were detected in the absence of lipid. Strong changes in the ter-
tiary structure during PLA2 activation were also identified. Initially, at 4
oC,
the near-UV CD spectra showed a weak negative band around 280 nm. Upon
a shift to 38 oC, strong positive CD bands rapidly developed around 250 and
280 nm, implying significant changes in the conformation and/or the micro-
environment of Tyr and Trp side chains of PLA2, possibly accompanied with
a global tertiary structure perturbation associated with deformation of the
abundant disulfide bonds in the protein. These experiments provide new in-
formation on the structure-function relationship of PLA2 by near-simulta-
neous measurements of PLA2 activity and its secondary and tertiary struc-
tures.
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Human P-glycoprotein (ABCB1) is important in pharmacokinetics, tissue dis-
tribution, oral bioavailability and disposition of therapeutic compounds. Over-
expression of P-glycoprotein can lead to adverse clinical effects such as the
failure of cancer chemotherapy by the induction of multidrug resistance.
Thus a detailed understanding of P-glycoprotein’s drug transport cycle is a pre-
requisite to modulating its various activities. Here we present a detailed ki-
netic and mechanistic model of drug transport by P-glycoprotein. This was
achieved by global fitting of time-based progress curves of the transport of
spin-labeled verapamil as a function of ATP concentrations and measurements
of the force-flux relationships observed during drug transport. By measuring
the ATPase activity simultaneously with the transport velocity in proteolipo-
somes containing purified P-glycoprotein we established a limiting stoichiom-
etry of one ATP hydrolyzed per spin-labeled verapamil molecule transported.
Next, using standard chemical kinetic rate laws, we compared different pro-
posed models of drug transport by trying to globally fit available experimental
data numerically to coupled differential equations generated by each compet-
ing model. Our original seed values and constraints were generated from mea-
surements of KM, Vmax, and Ki values for all reacting ligands during the
steady state transport cycle together with knowledge of the overall thermody-
namics of the transport cycle. We achieved a unique global fit of the progress
curves of spin-labeled verapamil transport as a function of ATP concentration.
A single internally consistent set of rate constants was shown to account for
the data. Additionally, these same rate constants also accounted for the exper-
imentally observed force-flux relationships when utilized in our ‘‘reaction
power stroke’’ model. In contrast we were not able to fit the data as uniquely
and as effectively with other competing drug transport models. Supported by
NIH grant GM52502.
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G-protein coupled receptors (GPCRs) are a large family of integral mem-
brane proteins involved in signal transduction pathways, making them ap-pealing drug targets for a wide spectrum of diseases. The recently solved
X-ray structures of beta1 (B1AR) and beta2 (B2AR) adrenergic receptors
bound to inverse agonists/antagonists open up a large field of potential inves-
tigations to understand the binding modes and mechanisms of activation of
GPCRs.
To investigate their structural and dynamic properties under pseudo in vivo
conditions, we performed extensive molecular dynamics simulations (in an ex-
plicit membrane) of adrenergic receptors in complex with partial inverse ago-
nists and agonists as well as in their apoform. To this end, we applied
MD-based enhanced sampling techniques (steered MD, metadynamics, .) to
describe ligand binding and to elucidate the process of ligand entrance and re-
lease.
In this contribution, we rationalize the differences in binding mode between
B1AR and B2AR for both agonists and antagonists (focusing on a limited set
of key residues surrounding the binding pocket that are different between
B1AR and B2AR). We also discuss main structural changes upon agonist/an-
tagonist binding also in comparison with the most thoroughly studied GPCR,
rhodopsin.
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Metabotropic glutamate receptors (mGluRs) are G protein coupled receptors
which are implicated in different brain functions and dysfunctions including
learning, memory, pain perception, neurodegeneration, schizophrenia and ad-
diction. Metabotropic glutamate receptor type 6 (mGluR6) is a subtype of
mGluRs which is exclusively expressed in ON-bipolar cells and is involved
in night vision. Recent genome-wide association studies have discovered in-
volvement of mGluR6 in heroin addiction. mGluR6 is emerging as a new
drug target but structure-function relationships of this receptor and in general
of mGluRs are poorly understood. These receptors have very low expression
levels in their native cells and are only active in a membrane environment.
The major problem in studying these receptors with biophysical approaches
is in obtaining sufficient quantities of functional protein. To overcome this,
we have constructed a tetracycline inducible mammalian stable cell line ex-
pressing full length human mGluR6. We optimized the detergent and buffer
conditions required for mGluR6 purification. We are developing a reliable,
quantitative in vitro assay for verifying the function of purified mGluR6
in different detergents. We have been successful in developing a medium
scale expression and purification system of mGluR6. Preliminary data sug-
gests that this receptor responds to a number of ligands relevant to its impli-
cated role in vision and addiction with changes in activity and structure as
evidenced by G protein binding and cysteine accessibility measurements, re-
spectively.
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BACE is a novel type I transmembrane aspartyl protease that has been im-
plicated in the pathogenesis of Alzheimer’s disease. Cleavage of the amy-
loid precursor protein by the beta-secretase, BACE, is the first step in the
production of the amyloid-beta peptide and is a prime target for therapeutic
intervention. Using circular dichroism, we provide evidence that show dif-
ferences in stability between active (pH 4.8) and inactive (pH 7.2) BACE.
Active BACE (Tm ~51
C) is comparably much less stable than the inactive
form (Tm ~84
C). In this study we have also examined Ca2þ binding to
BACE, the effect of this binding on the secondary and tertiary structural
characteristics of BACE, and the influence of this binding on the specific
activity of the purified protein. Initially, we used isothermal titration calo-
rimetry to characterize the Ca2þ-BACE interaction. Our results suggest that
there is a high affinity of binding (K¼ 2.0  105 M1) between Ca2þ and
BACE and that the binding process was exothermic (-3.5 kcal/mol). Circu-
lar dichroism and endogenous tryptophan fluorescence measurements dem-
onstrated that the secondary and tertiary structure, respectively, is sensitive
to increasing concentrations of Ca2þ. We also could demonstrate that
low concentrations of Ca2þ (mM) significantly increased the proteolytic ac-
tivity of BACE. Collectively, these results define a role for Ca2þ in both
modulating the structure and proteolytic activity of BACE and suggest
